Novocortex Competitors

The Epilepsy Foundation, a national non-profit with nearly 50 local organizations throughout the United States, has led the fight against seizures since 1968. The Foundation is an unwavering ally for individuals and families impacted by epilepsy and seizures. The mission of the Epilepsy Foundation is: to improve the quality of life for those affected by epilepsy through education, advocacy, research, and connection. The Foundation works to ensure that people with seizures have the opportunity to live their lives to their fullest potential.

Alto Neuroscience is redefining psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective medicines, helping patients get better faster. Alto's Precision Psychiatry Platform™ measures biomarkers like EEG and wearable data, behavioral patterns, genetics, and other factors to match patients with the treatment they are most likely to respond to. Our approach matches the right patient with the right Alto drug based on AI-derived brain biomarkers, redefining psychiatry at a time when the world needs it most.

NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain disorders. NeuroMetrix, Inc. is a wholly-owned subsidiary of electroCore, Inc. The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. NeuroMetrix markets the following products: DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com. NeuroMetrix, Inc. is a wholly-owned subsidiary of electroCore, Inc. While operating under the ownership of electroCore, NeuroMetrix will continue to provide its Quell products and services under its established brand. Our Terms of Service and Privacy Policy have been updated to reflect this change. Please review these updates to understand how this new relationship may affect your experience with us. If you have any questions, please contact us at 888-903-2673.